129 related articles for article (PubMed ID: 22405329)
1. The predictive role of early activation of natural killer cells in septic shock.
de Pablo R; Monserrat J; Torrijos C; Martín M; Prieto A; Alvarez-Mon M
Crit Care; 2012 Dec; 16(2):413. PubMed ID: 22405329
[TBL] [Abstract][Full Text] [Related]
2. Early natural killer cell counts in blood predict mortality in severe sepsis.
Andaluz-Ojeda D; Iglesias V; Bobillo F; Almansa R; Rico L; Gandía F; Loma AM; Nieto C; Diego R; Ramos E; Nocito M; Resino S; Eiros JM; Tamayo E; de Lejarazu RO; Bermejo-Martin JF
Crit Care; 2011; 15(5):R243. PubMed ID: 22018048
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients.
Monserrat J; de Pablo R; Reyes E; Díaz D; Barcenilla H; Zapata MR; De la Hera A; Prieto A; Alvarez-Mon M
Crit Care; 2009; 13(1):R26. PubMed ID: 19243622
[TBL] [Abstract][Full Text] [Related]
4. Phenotype and functions of natural killer cells in critically-ill septic patients.
Forel JM; Chiche L; Thomas G; Mancini J; Farnarier C; Cognet C; Guervilly C; Daumas A; Vély F; Xéridat F; Vivier E; Papazian L
PLoS One; 2012; 7(12):e50446. PubMed ID: 23236375
[TBL] [Abstract][Full Text] [Related]
5. Prognostic markers among Egyptian children with sepsis in the Intensive Care Units, Cairo University Hospitals.
Ibrahiem SK; Galal YS; Youssef MR; Sedrak AS; El Khateeb EM; Abdel-Hameed ND
Allergol Immunopathol (Madr); 2016; 44(1):46-53. PubMed ID: 26657169
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases.
Cui N; Zhang H; Chen Z; Yu Z
J Int Med Res; 2019 Apr; 47(4):1573-1579. PubMed ID: 30656987
[TBL] [Abstract][Full Text] [Related]
7. A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock.
Yoo JW; Lee JR; Jung YK; Choi SH; Son JS; Kang BJ; Park TS; Huh JW; Lim CM; Koh Y; Hong SB
Korean J Intern Med; 2015 Jul; 30(4):471-7. PubMed ID: 26161013
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic value of lipopolysaccharide binding protein and procalcitonin in patients with severe sepsis and septic shock admitted to intensive care].
García de Guadiana-Romualdo LM; Rebollo-Acebes S; Esteban-Torrella P; Jiménez-Sánchez R; Hernando-Holgado A; Ortín-Freire A; Viqueira-González M; Trujillo-Santos J; Jiménez Santos E; Pedregosa Díaz J; Albaladejo-Otón MD; Allegue-Gallego JM
Med Intensiva; 2015 May; 39(4):207-12. PubMed ID: 24953001
[TBL] [Abstract][Full Text] [Related]
9. The influence of a change in septic shock definitions on intensive care epidemiology and outcome: comparison of sepsis-2 and sepsis-3 definitions.
Driessen RGH; van de Poll MCG; Mol MF; van Mook WNKA; Schnabel RM
Infect Dis (Lond); 2018 Mar; 50(3):207-213. PubMed ID: 28950786
[TBL] [Abstract][Full Text] [Related]
10. A shift toward inhibitory receptors and impaired effector functions on NK cells contribute to immunosuppression during sepsis.
Feng T; Liao X; Yang X; Yang C; Lin F; Guo Y; Kang Y; Li H
J Leukoc Biol; 2020 Jan; 107(1):57-67. PubMed ID: 31385383
[TBL] [Abstract][Full Text] [Related]
11. [Immunological defects in septic shock. Deficiency of natural Killer cells and T-lymphocytes].
Puente J; Miranda D; Gaggero A; Maturana P; Godoy G; Salazar R; Sepulveda C
Rev Med Chil; 1991 Feb; 119(2):142-6. PubMed ID: 1824155
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin-3 Predicts Short- and Mid-term Mortality in Patients with Sepsis and Septic Shock During Intensive Care Treatment.
Hamed S; Behnes M; Pauly D; Lepiorz D; Barre M; Becher T; Lang S; Akin I; Borggrefe M; Bertsch T; Hoffmann U
Clin Lab; 2018 Jun; 64(6):999-1011. PubMed ID: 29945330
[TBL] [Abstract][Full Text] [Related]
13. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of ADAMTS13 in patients with severe sepsis and septic shock.
Azfar MF; Khan MF; Habib SS; Aseri ZA; Zubaidi AM; Aguila DO; Suriya MO; Ullah H
Clin Invest Med; 2017 Apr; 40(2):E49-E58. PubMed ID: 28447577
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of circulating endothelial cells in patients with severe sepsis or septic shock.
Yoo JW; Moon JY; Hong SB; Lim CM; Koh Y; Huh JW
Infect Dis (Lond); 2015 Jun; 47(6):393-8. PubMed ID: 25746599
[TBL] [Abstract][Full Text] [Related]
16. IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function.
Guo Y; Luan L; Patil NK; Wang J; Bohannon JK; Rabacal W; Fensterheim BA; Hernandez A; Sherwood ER
J Immunol; 2017 Feb; 198(3):1320-1333. PubMed ID: 28031340
[TBL] [Abstract][Full Text] [Related]
17. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
[TBL] [Abstract][Full Text] [Related]
18. Application of the new Sepsis-3 definition in a cohort of patients with severe sepsis and septic shock admitted to Intensive Care Unit from the Emergency Department.
García-Gigorro R; Molina-Collado Z; Sáez-de la Fuente I; Sanchez-Izquierdo JÁ; Montejo González JC
Med Clin (Barc); 2019 Jan; 152(1):13-16. PubMed ID: 29680459
[TBL] [Abstract][Full Text] [Related]
19. Activated cytotoxic T cells and NK cells in severe sepsis and septic shock and their role in multiple organ dysfunction.
Zeerleder S; Hack CE; Caliezi C; van Mierlo G; Eerenberg-Belmer A; Wolbink A; Wuillenmin WA
Clin Immunol; 2005 Aug; 116(2):158-65. PubMed ID: 15993363
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell deficiency experiences higher risk of sepsis after critical intracerebral hemorrhage.
Feng Y; Wu Q; Zhang T; Chen J; Wu X
Int J Immunopathol Pharmacol; 2021; 35():20587384211056495. PubMed ID: 34931551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
